JENBURKT PHARMACEUTICALS
|
The Current P/S Ratio of JENBURKT PHARMACEUTICALS is 3.32.
Share Price | ₹1,127.0 | Jan 30,2025 |
Market Cap | ₹495.9 Cr | |
Sales-TTM | ₹149.5 Cr | TTM-Standalone Results |
Price/Sales | 3.32x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of JENBURKT PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹495.9 Cr] as on Jan 30,2025
(/) Sales [ ₹149.5 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 3.32x ]
Thus, for JENBURKT PHARMACEUTICALS , the investors are currently willing to pay '3.32 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of JENBURKT PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of JENBURKT PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of JENBURKT PHARMACEUTICALS
PS Ratio Performance Analysis for JENBURKT PHARMACEUTICALS
- JENBURKT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.86x.
- JENBURKT PHARMACEUTICALS 's operated at median p/e ratio of 2.1x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JENBURKT PHARMACEUTICALS 's p/e ratio peaked in Mar2023 at 2.15x.
- JENBURKT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 1.23x.
How does JENBURKT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
JENBURKT PHARMACEUTICALS | 149.5 | 3.32 | 495.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.32 | 418,744.0 |
CIPLA LTD | 26,981.2 | 4.43 | 119,474.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.25 | 101,599.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.47 | 95,929.3 |
DIVIS LABORATORIES LTD | 8,614.0 | 17.18 | 148,023.0 |
MANKIND PHARMA LTD | 11,641.0 | 8.82 | 102,663.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 10.05 | 113,621.0 |
LUPIN LTD | 21,431.3 | 4.40 | 94,191.9 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.25 | 68,055.4 |
ABBOTT INDIA LTD | 6,066.1 | 9.16 | 55,558.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JENBURKT PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.25x |
Max industry PS | 17.18x |
Median industry PS | 4.47x |
Average industry PS | 6.88x |
You may also like the below Video Courses